
INVA
Healthcare · Biotechnology · $1.35B market cap
$19.03+0.06 (+0.3%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -22.0% over 90 days · 30-day revisions 1 up, 1 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 4, 2026 | After the close | 0.49 | 0.50 | +2.0% |
| Aug 5, 2026 | After the close | 0.56 | 0.59 | +5.4% |
| May 6, 2026 | After the close | 0.43 | 0.47 | +9.3% |
| Mar 4, 2026 | Time not confirmed | 0.57 | 1.94 | +238.7% |
| Nov 5, 2025 | After the close | 0.46 | 1.08 | +134.8% |
| Aug 6, 2025 | After the close | 0.50 | 0.77 | +54.0% |
| May 6, 2025 | Before the open | 0.33 | -0.74 | -325.1% |
| Feb 26, 2025 | After the close | 0.41 | 0.26 | -36.6% |
| Nov 6, 2024 | After the close | 0.27 | 0.12 | -55.6% |
| Jul 31, 2024 | After the close | 0.24 | -0.55 | -329.2% |
| May 8, 2024 | After the close | 0.17 | 0.46 | +170.6% |
| Feb 29, 2024 | After the close | 0.23 | 0.76 | +230.4% |
| Nov 1, 2023 | After the close | 0.27 | 0.18 |
Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally. Its royalty portfolio includes RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol, and an inhaled corticosteroid, and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, and ABA, VI. The company also markets…
| -33.3% |
| Aug 2, 2023 | After the close | 0.26 | 0.02 | -92.3% |
| May 9, 2023 | After the close | 0.23 | 0.42 | +82.6% |
| Feb 28, 2023 | After the close | 0.23 | -0.98 | -526.1% |
| Nov 9, 2022 | After the close | 2.24 | 0.54 | -75.9% |
| Jul 27, 2022 | After the close | 0.44 | 0.62 | +40.9% |
| Apr 27, 2022 | After the close | 0.48 | 0.44 | -8.3% |
| Feb 9, 2022 | After the close | 0.41 | 0.14 | -65.9% |
| Oct 27, 2021 | After the close | 0.43 | 0.90 | +109.3% |
| Jul 28, 2021 | After the close | 0.29 | 0.90 | +210.3% |
| Apr 28, 2021 | After the close | -0.01 | 0.84 | +8500.0% |
| Feb 3, 2021 | After the close | 0.40 | 0.55 | +37.5% |
| Oct 28, 2020 | After the close | 0.42 | 0.46 | +9.5% |
| Jul 29, 2020 | After the close | 0.32 | 0.33 | +3.1% |
| Apr 29, 2020 | After the close | 0.36 | 0.42 | +16.7% |
| Feb 5, 2020 | After the close | 0.50 | 0.42 | -16.0% |
| Oct 30, 2019 | After the close | 0.37 | 0.36 | -2.7% |
| Jul 24, 2019 | After the close | 0.42 | 0.34 | -19.0% |
| May 1, 2019 | After the close | 0.36 | 0.31 | -13.9% |
| Feb 6, 2019 | After the close | 0.65 | 0.60 | -7.7% |
| Oct 31, 2018 | After the close | 0.42 | 0.44 | +4.8% |
| Jul 26, 2018 | After the close | 0.55 | 0.49 | -10.9% |
| Apr 26, 2018 | Before the open | 0.53 | 0.27 | -49.1% |
| Feb 8, 2018 | After the close | 0.49 | 0.48 | -2.0% |